Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

被引:429
作者
Drzezga, A
Lautenschlager, N
Siebner, H
Riemenschneider, M
Willoch, F
Minoshima, S
Schwaiger, M
Kurz, A
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-8000 Munich, Germany
[3] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England
[4] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
关键词
cerebral glucose metabolism; Alzheimer's disease; dementia; mild cognitive impairment; positron emission tomography; follow-up;
D O I
10.1007/s00259-003-1194-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A high percentage of patients with mild cognitive impairment (MCI) develop clinical dementia of the Alzheimer type (AD) within 1 year. The aim of this longitudinal study was to identify characteristic patterns of cerebral metabolism at baseline in patients converting from MCI to AD, and to evaluate the changes in these patterns over time. Baseline and follow-up examinations after 1 year were performed in 22 MCI patients (12 males, 10 females, aged 69.8+/-5.8 years); these examinations included neuropsychological testing, structural cranial magnetic resonance imaging and fluorine-18 fluorodeoxyglucose positron emission tomography (PET) evaluation of relative cerebral glucose metabolic rate (rCMRglc). Individual PET scans were stereotactically normalised with NEUROSTAT software (Univ. of Michigan, Ann Arbor, USA). Subsequently, statistical comparison of PET data with an age-matched healthy control population and between patient subgroups was performed using SPM 99 (Wellcome Dept. of Neuroimaging Sciences, London, UK). After 1 year, eight patients (36%) had developed probable AD (referred to as MCIAD), whereas 12 (55%) were still classified as having stable MCI (referred to as MCIMCI). Compared with the healthy control group, a reduced rCMRglc in AD-typical regions, including the temporoparietal and posterior cingulate cortex, was detected at baseline in patients with MCIAD. Abnormalities in the posterior cingulate cortex reached significance even in comparison with the MCIMCI group. After 1 year, MCIAD patients demonstrated an additional bilateral reduction of rCMRglc in prefrontal areas, along with a further progression of the abnormalities in the parietal and posterior cingulate cortex. No such changes were observed in the MCIMCI group. In patients with MCI, characteristic cerebral metabolic differences can be delineated at the time of initial presentation, which helps to define prognostic subgroups. A newly emerging reduction of rCMRglc in prefrontal cortical areas is associated with the transition from MCI to AD.
引用
收藏
页码:1104 / 1113
页数:10
相关论文
共 35 条
[1]   Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment [J].
Arnáiz, E ;
Jelic, V ;
Almkvist, O ;
Wahlund, LO ;
Winblad, B ;
Valind, S ;
Nordberg, A .
NEUROREPORT, 2001, 12 (04) :851-855
[2]  
Bartenstein P, 1997, J NUCL MED, V38, P1095
[3]   Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: A SPECT blood flow study [J].
Brown, DRP ;
Hunter, R ;
Wyper, DJ ;
Patterson, J ;
Kelly, RC ;
Montaldi, D ;
McCulloch, J .
JOURNAL OF PSYCHIATRIC RESEARCH, 1996, 30 (02) :109-&
[4]  
Drzezga A, 1999, J NUCL MED, V40, P737
[5]   Cognitive process in preclinical phase of dementia [J].
Fabrigoule, C ;
Rouch, I ;
Taberly, A ;
Letenneur, L ;
Commenges, D ;
Mazaux, JM ;
Orgogozo, JM ;
Dartigues, JF .
BRAIN, 1998, 121 :135-141
[6]  
Gauggel S, 1995, GERIATRIE PRAXIS, V6, P33
[7]   Clinical application of positron emission tomography for diagnosis of dementia [J].
Ishii, K .
ANNALS OF NUCLEAR MEDICINE, 2002, 16 (08) :515-525
[8]  
Ishii K, 2001, J NUCL MED, V42, P548
[9]  
Kogure D, 2000, J NUCL MED, V41, P1155
[10]  
Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.0.CO